Ponstel
Migraines' Brain Changes Not Linked to Mental Harm »
"Nov. 13, 2012 -- Women who get migraines are more likely than those who don't to develop small areas of tissue changes in their brains, a new study shows. At the same time, these changes do not seem to affect the women's thinking or memory.
"...Read the Migraines' Brain Changes Not Linked to Mental Harm article »
Ponstel
INDICATIONS
Carefully consider the potential benefits and risks of PONSTEL (mefenamic acid) and other treatment options before deciding to use PONSTEL (mefenamic acid) . Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).
PONSTEL (mefenamic acid) is indicated:
- For relief of mild to moderate pain in patients =14 years of age, when therapy will not exceed one week (7 days).
- For treatment of primary dysmenorrhea.
DOSAGE AND ADMINISTRATION
Carefully consider the potential benefits and risks of PONSTEL (mefenamic acid) and other treatment options before deciding to use PONSTEL (mefenamic acid) . Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).
After observing the response to initial therapy with PONSTEL (mefenamic acid) , the dose and frequency should be adjusted to suit an individual patient's needs.
For the relief of acute pain in adults and adolescents =14 years of age, the recommended dose is 500 mg as an initial dose followed by 250 mg every 6 hours as needed, usually not to exceed one week.4
For the treatment of primary dysmenorrhea, the recommended dose is 500 mg as an initial dose followed by 250 mg every 6 hours, given orally, starting with the onset of bleeding and associated symptoms. Clinical studies indicate that effective treatment can be initiated with the start of menses and should not be necessary for more than 2 to 3 days.5
HOW SUPPLIED
Ponstel (mefenamic acid) is available as 250 mg blue-banded, ivory capsules, imprinted with "FHPC 400" and "PONSTEL® (mefenamic acid) ".
Bottles of 100...................NDC 59630-400-10
Storage
Store at 20- 25°C (68- 77°F); excursions permitted to 15-30°C (59-86°F) [See USP Controlled Room Temperature].
REFERENCES
4. Glazko AJ: Experimental observations of flufenamic, mefenamic, and meclofenamic acids. Part III. Metabolic disposition, in Fenamates in Medicine. A Symposium, London, 1966. Annals of Physical Medicine, Supplement, pp 23-36, 1967.
5. Data on file, First Horizon (Protocol 356).
Distributed by: Atlanta, GA 30328. Revised March 2007. FDA Rev date: 3/6/2008
Last reviewed on RxList: 3/25/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Ponstel Information
Ponstel - User Reviews
Ponstel User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Here is a collection of user reviews for the medication Ponstel sorted by most helpful.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Living Better
Find the secrets to longer life.
Updated & New
